Does Altimmune (ALT) Have the Potential to Rally 229.28% as Wall Street Analysts Expect?

Altimmune, Inc. (ALT) closed the last trading session at $5.43, gaining 28.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 17.88 indicates a 229.3% upside potential.The average comprises eight short-term price targets ranging from a low of $1.00 to a high of$ 28.00, with a standard deviation of $8.81. While the lowest estimate indicates a decline of 81.6% from the current price ...